Welcome to the e-CCO Library Archive!

search
                             
search by: 
Filter:
P118. Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic severity in patients with inflammatory bowel diseases
P118. Previous misdiagnosis and diagnostic delay in inflammatory bowel diseases
P118. Vitamin D status and bone mineral density in patients recently diagnosed with ulcerative colitis
Authors:

G. Dumitrescu1, I.A. Pintilie1, M. Dranga1, E. Toader1, C. Mihai1, C. Cijevschi Prelipcean1, 1University of Medicine and Pharmacy Gr. T. Popa, Center of Gastroenterology and Hepatology “St. Spiridon” Hospital, Iasi, Romania

P118

Incidence and Severity of Pre-pouch Ileitis: A Distinct Disease Entity or a Manifestation of Refractory

Authors:

D. de Jong*1, M. Samaan2, 3, S. Sahami4, S. Morgan2, K. Fragkos2, S. Subramaniam2, K. Kok2, J. Makanyanga2, I. Barnova2, H. Saravanapavan2, I. Parisi2, S. Di Caro2, F. Rahman2, S. McCartney2, S.L. Bloom2, G. van den Brink1, M. Lowenberg1, C. Ponsioen1, C.J. Buskens4, P.J. Tanis4, A. de Buck van Overstraeten5, A. D'Hoore5, W. Bemelman4, G.R. D'Haens1, 3

1Academic Medical Center, Inflammatory Bowel Disease Centre, Amsterdam, Netherlands, 2University College London, Gastroenterology, London, United Kingdom, 3Robarts, Robarts Clinical Trials Inc., Amsterdam, Netherlands, 4Academic Medical Centre, Department of Surgery, Amsterdam, Netherlands, 5University Hospitals Leuven, Department of Surgery, Leuven, Belgium

P119.

The diagnostic value of a new fecal marker matrix metalloprotease-9 in different types of inflammatory bowel diseases

Authors:

K. Farkas1, Z. Sarodi1, A. Bálint1, I. Földesi1, G. Lázár2, Z. Simonka2, L. Tiszlavicz3, M. Szücs4, T. Nyári4, F. Nagy1, Z. Szepes1, R. Bor1, A. Annaházi1, R. Roka1, T. Wittmann1, T. Molnár1, 1University of Szeged, First Department of Medicine, Szeged, Hungary, 2University of Szeged, Department of Surgery, Szeged, Hungary, 3University of Szeged, Department of Pathology, Szeged, Hungary, 4University of Szeged, Department of Medical Physics and Informatics, Szeged, Hungary

P119. Assessment of Crohn's disease activity by confocal laser endomicroscopy
P119. Bone mineral density in Portuguese patients with Crohn's disease
P119. Vitamin D status and bone mineral density in patients recently diagnosed with Crohn's disease
Authors:

G. Dumitrescu1, O. Nedelciuc1, M. Badea1, M. Dranga1, C. Mihai1, C. Cijevschi Prelipcean1, 1University of Medicine and Pharmacy Gr. T. Popa, Center of Gastroenterology and Hepatology “St. Spiridon” Hospital, Iasi, Romania

P119

Evaluation of Crohn's disease: CRP in the midst of MRI and endoscopy

Authors:

M. Serio*1, K. Efthymakis1, A. Pierro2, F. Laterza1, A. Milano1, G. Maselli2, A. Bonitatibus1, G. Sallustio2, M. Neri1

1Università "G. D'Annunzio", Medicine and Aging Sciences and CESI, Chieti, Italy, 2Fondazione di Ricerca e Cura "Giovanni Paolo II", Università Cattolica del Sacro Cuore, Radiology Department, Campobasso, Italy

P120.

The concentrations of calprotectin in stool samples vary during the day in patients with active ulcerative colitis

Authors:

A. Lasson1, P.-O. Stotzer2, L. Öhman2, S. Isaksson2, H. Strid2, 1Södra Älvsborgs Hospital, Department of Internal Medicine, Borås, Sweden, 2Sahlgrenska University Hospital, Department of Internal Medicine, Gothenburg, Sweden

P120. A new computed assisted algorithm allows automatic evaluation of inflammatory activity in inflammatory bowel disease (IBD) using confocal laser endomicroscopy (CLE)
P120. Magnetic resonance enterography (MRE) in children with Crohn's disease: Results from the Belgian Pediatric Crohn's Registry (Belcro)
P120. Vitamin D deficiency is common in Crohn's disease but also in healthy controls: a prospective case-control study
Authors:

J. de Bruyn1, R. van Heeckeren1, K. Gecse1, C. Ponsioen1, G. van den Brink1, M. Löwenberg1, A.J. Bredenoord1, G. Frijstein2, G. D'Haens1, 1Academic Medical Center, Gastro-enterology, Amsterdam, Netherlands, 2Academic Medical Center, Occupational Health, Safety and Environment, Amsterdam, Netherlands

P120

Consistently low albumin level is associated with subsequent bowel stenosis, fistula or perforation in patients with Crohn's disease.

Authors:

G. Radford-Smith*1, E. Ferguson2, K. Hanigan3, L. Simms3, J. Irwin1

1Royal Brisbane and Women's Hospital, Gastroenterology, Brisbane, Australia, 2Royal Brisbane & Women's Hospital, Department of Gastroenterology, Brisbane, Australia, 3QIMR Berghofer Medical Research Institute, Complex Diseases, Brisbane, Australia

P121.

The clinical characteristics of Crohn's disease patients with free perforation in Korea

Authors:

Y.S. Kim1, Y.S. Doh1, H.J. Jung1, J.h. Cheon2, Y.-H. Kim3, B.D. Ye4, J.W. Kim5, J.P. Im5, J.S. Kim5, 1Inje University College of Medicine, Internal Medicine, Seoul, Korea, Republic of, 2Yonsei University College of Medicine, Internal Medicine, Seoul, Korea, Republic of, 3Sungkyunkwan University School of Medicine, Internal Medicine, Seoul, Korea, Republic of, 4University of Ulsan College of Medicine, Internal Medicine, Seoul, Korea, Republic of, 5Seoul National University College of Medicine, Internal Medicine, Seoul, Korea, Republic of

P121. Inter-observer agreement for Crohn's disease sub-phenotypes using the Montreal Classification: How good are we? A multi-centre Australasian study
P121. Specialized IBD management at emergency room limits the need for hospital admission in IBD patients
P121. Vitamin D deficiency in Crohn's disease Portuguese patients: prevalence and risk factors
Authors:

R. Cerqueira1, M. Correia2, C. Fernandes2, C. Manso3, 1S Sebastiao Hospital, Gastroenterology, Porto, Portugal, 2S Sebastiao Hospital, Portugal, 3University Fernando Pessoa, Biostatistics, Porto & REQUIMTE-UP, Portugal

P121

Delay in diagnosis of Crohn's disease: description over time and identification of associated factors. A 21-year population based study

Authors:

C. Mickaël*1, H. Sarter2, M. Fumery3, L. Armengol-Debeir4, E. Laberenne5, F. Vasseur2, D. Turck6, B. Pariente1, L. Dauchet7, L. Peyrin-Biroulet8, C. Gower-Rousseau9, G. Savoye4

1Lille University Hospital, Gastroenterology, Lille, France, 2Lille University Hospital, Epidemiology, Lille, France, 3Amiens University Hospital, Gastroenterology, Amiens, France, 4Rouen University Hospital, Gastroenterology, Rouen, France, 5Seclin Hospital, Gastroenterology, Seclin, France, 6Lille University Hospital, Pediatrics, Lille, France, 7Lille University Hospital , Public Health, Lille, France, 8Nancy University Hospital , Gastroenterology , Nancy, France, 9Lille University Hospital , Biostatistics, Lille, France

P122.

The clinical and immunological significance of low level of infliximab in the absence of anti-infliximab antibodies in patients with IBD

Authors:

B. Ungar1, A. Anafy1, M. Yavzori1, O. Picard1, E. Fudim1, U. Kopylov1, Y. Ron2, H. Yanai2, I. Dotan2, Y. Chowers3, R. Eliakim1, S. Ben-Horin1, 1Chaim Sheba Medical Center, Gastroenterology, Ramat Gan, Israel, 2Tel Aviv Sourasky Medical Center, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, IBD Center, Department of Gastroenterology and Liver Diseases, Tel Aviv, Israel, 3Rambam Health Care Campus & Bruce Rappaport School of Medicine, Technion Institute of Technology, Gastroenterology department, Haifa, Israel